产品介绍
猫白血病是猫常见的非创伤性致死疾病,是由猫白血病病毒和猫肉瘤病毒引起的恶性肿瘤性传染病。主要特征是恶性淋巴肿瘤、骨髓性白血病以及变性性胸腺萎缩和非再生性贫血等,其中对猫最严重的是恶性淋巴肿瘤。幼猫易感性高,随年龄增长易感性降低。
|
产品名称
|
类型
|
货号
|
来源
|
建议使用
|
应用
|
|
FLV66
|
rAg
|
|
E.coli
|
包被/标记
|
EIA、LF
|
【仅供科学研究使用】
相关产品:
| 产品名称 |
点击数 |
| Anti-Human CD48 Recombinant Antibody , APC|抗人CD48重组抗体,APC(靶标:人CD48(SLAMF2)) |
405 |
| Anti-Human CD48 Recombinant Antibody, APC|抗人CD48重组抗体,APC(靶标:人CD48(SLAMF2)) |
233 |
| Anti-Human CXCL1/NAP-3/GRO-alpha Recombinant Antibody , APC|抗人CXCL1/NAP-3/GRO-α重组抗体,APC(靶标:人CXC趋化因子配体1(GRO-α)) |
202 |
| Anti-Human CD7 Recombinant Antibody, APC|抗人CD7重组抗体,APC(靶标:人CD7) |
190 |
| Anti-Human CD7 Recombinant Antibody, APC|抗人CD7重组抗体,APC(靶标:人CD7) |
201 |
| Anti-Human CSF1/M-CSF Recombinant Antibody , APC|抗人CSF1/M-CSF重组抗体,APC(靶标:人巨噬细胞集落刺激因子) |
295 |
| Anti-Human CD140b/PDGFRB Recombinant Antibody , APC|抗人CD140b/PDGFRB重组抗体,APC(靶标:人PDGF受体β) |
354 |
| Anti-Human CD140b/PDGFRB Recombinant Antibody, APC|抗人CD140b/PDGFRB重组抗体,APC(靶标:人PDGF受体β) |
378 |
| Anti-Human TACSTD2/TROP2 Recombinant Antibody , APC|抗人TACSTD2/TROP2重组抗体,APC(靶标:人滋养层细胞表面抗原2) |
327 |
| Anti-Human TACSTD2/TROP2 Recombinant Antibody, APC|抗人TACSTD2/TROP2重组抗体,APC(靶标:人滋养层细胞表面抗原2) |
365 |
| Anti-Human C1S Recombinant Antibody , APC|抗人C1S重组抗体,APC(靶标:人补体C1s) |
310 |
| Anti-Human CSF3/G-CSF Recombinant Antibody , APC|抗人CSF3/G-CSF重组抗体,APC(靶标:人粒细胞集落刺激因子) |
322 |
| Anti-Human GZMB Recombinant Antibody, APC|抗人GZMB重组抗体,APC(靶标:人颗粒酶B) |
179 |
| Anti-Human GZMB Recombinant Antibody, APC|抗人GZMB重组抗体,APC(靶标:人颗粒酶B) |
185 |
| Anti-Human IL8/CXCL8 Recombinant Antibody , APC|抗人IL8/CXCL8重组抗体,APC(靶标:人白细胞介素-8) |
255 |
| Anti-Human CCL3/MIP-1-alpha Recombinant Antibody , APC|抗人CCL3/MIP-1-α重组抗体,APC(靶标:人CC趋化因子配体3(MIP-1α)) |
198 |
| Anti-Human OPN/SPP1 Recombinant Antibody , APC|抗人OPN/SPP1重组抗体,APC(靶标:人骨桥蛋白) |
496 |
| Anti-Human TGFB3/TGF-beta-3 Recombinant Antibody , APC|抗人TGFB3/TGF-β-3重组抗体,APC(靶标:人转化生长因子β3) |
206 |
| Anti-Human MAPT/Tau/PHF-tau Recombinant Antibody, APC|抗人MAPT/Tau/PHF-tau重组抗体,APC(靶标:人Tau蛋白) |
198 |
| Anti-Human MAPT/Tau/PHF-tau Recombinant Antibody , APC|抗人MAPT/Tau/PHF-tau重组抗体,APC(靶标:人Tau蛋白) |
257 |